Antiarrhythmics Flashcards
Nexterone, Pacerone
Class III antiarrhythmic
Amiodarone
Nexterone, Pacerone:
Boxed Warnings
Pulmonary toxicity -> baseline CXR & PFTs
Hepatotoxicity -> baseline LFTs
For life-threatening arrhythmias only; proarrhythmic, must be hospitalized for IV loading dose
Nexterone, Pacerone:
Contraindications
Iodine hypersensitivity
Nexterone, Pacerone:
Warnings
Hyper & Hypothyroidism (hypo more common) - amiodarone partially inhibits peripheral conversion of T4 to T3
visual impairment
photosensitivity (slate blue skin)
peripheral neuropathy
SJS/TENS
Nexterone, Pacerone:
ADE
hypotension
bradycardia
corneal microdeposits
photosensitivity (sun protection required)
Nexterone, Pacerone:
Monitoring
ECG, BP, HR, electrolytes
LFTs Q6 months
Thyroid function Q3-6 months
CXR annually
regular eye exams
Nexterone, Pacerone:
Notes
- infusions > 2h require non-PVC container (PVC tubing is fine)
- choice antiarrhythmic in HF
- decrease infusion rate or DC as needed with hypotension or bradycardia
- IV admin: use 0.22 micron filter; central line preferred
- incompatible with heparin (flush with saline)
- many Y-site additive incompatibilities
- t1/2 40-60 days
Nexterone, Pacerone:
this drug is an ______ of CYP ___, ___, ___, & ___
inducer of CYP 2C9, 2D6, 3A4, & P-gp
Nexterone, Pacerone:
Dose adjustments to other CV meds when starting this agent
decrease digoxin by 50%
decrease warfarin by 30-50%
do not exceed:
- 20 mg/day simvastatin
- 40 mg/day rosuvastatin
Nexterone, Pacerone:
DDI with NDHP CCBs, digoxin, BB, & clonidine
additive effect
bradycardia
Sofosbuvir can ______ the _______ effect of amiodarone. Do not use together.
Sofosbuvir can enhance the bradycardic effect of amiodarone
Digitek, Lanoxin
Na-K-ATPase blocker
Digoxin
decreases HR by increasing force of contraction (positive inotrope)
Digitek, Lanoxin:
Contraindication
Ventricular fibrillation
Digitek, Lanoxin:
Warnings
vesicant
Digitek, Lanoxin:
ADE
dizziness
mental disturbances
N/V/D